OBJECTIVE: To evaluate the curative effects of transcatheter closure on @entity1757 ( @entity1757 ) using unbalanced Amplatzer asymmetric @entity1757 occluder (AAVSDO). METHODS: The data of 68 @entity1 of @entity1757 with a diameter of 6.7 mm (3 to 12 mm) and the diameter of ventricular septal rim below the aortic valve of 2.7 +/- 1.1 mm (1-5 mm), 27 males and 41 females, aged 15.6 +/- 11.5 (1.5-44), weighing 42.8 +/- 15.2 kg (10-72 kg), treated with AAVSDO, the diameter of which was 1-2 mm larger than the largest diameter of the defects determined by angled left ventriculography, from September 2002 to January 2005 were prospectively analyzed. The @entity1 were followed up for 221 +/- 130 days (90 to 750 days). RESULTS: Seventy-one procedures were performed. The device was implanted successfully in 65 of the 68 @entity1 (95.6%). The selected device diameter was 8.4 mm (4 to 14 mm). Device was lost in one @entity1 during the procedure, which was successfully managed by recapturing the device with a snare device and redeploying it. During the procedure, transient complete @entity714 and @entity714 occurred in 6 and 5 @entity1 respectively. On follow-up evaluation, transient junctional rhythm occurred in one @entity1 , and accelerated ventricular rhythm in 1. After deployment of the device, the immediate complete closure rate was 43% (28/68), increased to 81.5% (53/68) on the day next to the procedure, and reached 100% 6 months after. One @entity1 adopted surgical reparation because @entity2142 occurred after the device implanted. The hospitalization time was 4.5 +/- 3.6 days (2-8 days). The X-ray exposure time was 14.8 +/- 10.7 min (6-48 min). The procedure time 72.6 +/- 38.7 min (35-186 min). One @entity1 was diagnosed as with @entity1150 because of right leg swelling at the seventh day after the procedure. The symptoms disappeared after anticoagulation treatment with low molecule weight heparin. During the scheduled long-term follow-up all @entity1 were doing well. No episode of @entity884 , procedure-related @entity204 , or wire disruption was recorded. CONCLUSION: The initial and long-term follow-up results of transcatheter closure of @entity1757 are promising with high success and occlusion rates. Transcatheter closure of @entity1757 using AAVSDO appears to be the first line choice for suitable @entity1 with such defects.

[Effects of transcatheter closure of XXXX : intermediate and long-term follow-up of 68 cases].

@entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity714 :: ('MESH:D002037', 'Disease') :: ['right bundle branch block', 'left bundle branch block'] @entity1757 :: ('MESH:D006345', 'Disease') :: ['PMVSDs', 'ventricular septal defect', 'perimembranous ventricular septal defects'] @entity1150 :: ('MESH:D020246', 'Disease') :: ['deep vein thrombosis'] @entity2142 :: ('MESH:D006461', 'Disease') :: ['hemolysis'] @entity204 :: ('MESH:D003643', 'Disease') :: ['death'] @entity884 :: ('MESH:D004696', 'Disease') :: ['endocarditis']
@entity1757 :: (MESH:D006345,Disease) :: ['perimembranous ventricular septal defects']
